MX360663B - Enfermedad tromboembolica. - Google Patents

Enfermedad tromboembolica.

Info

Publication number
MX360663B
MX360663B MX2017009492A MX2017009492A MX360663B MX 360663 B MX360663 B MX 360663B MX 2017009492 A MX2017009492 A MX 2017009492A MX 2017009492 A MX2017009492 A MX 2017009492A MX 360663 B MX360663 B MX 360663B
Authority
MX
Mexico
Prior art keywords
thromboemoblic
disease markers
relates
thromboembolism
risk
Prior art date
Application number
MX2017009492A
Other languages
English (en)
Inventor
Eduardo Salas
José Manuel Soria
Miroslava Ogorelkova
Roberto Elosua
Sergio Castillo
Joan S Vila
Original Assignee
Gendiag Exe Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46320920&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX360663(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gendiag Exe Sl filed Critical Gendiag Exe Sl
Publication of MX360663B publication Critical patent/MX360663B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invención se refiere a un procedimiento para una evaluación más apropiada del riesgo de un acontecimiento tromboembólico basándose en la presencia de diferentes variantes genéticas. La invención también se refiere a un procedimiento para determinar el riesgo de padecer una enfermedad tromboembólica combinando la ausencia o la presencia de uno o más marcadores polimórficos en una muestra del sujeto que presenta factores de riesgo convencionales para tromboembolia así como también a medios implementados por computadora para llevar a cabo dicho procedimiento.
MX2017009492A 2011-06-16 2012-06-13 Enfermedad tromboembolica. MX360663B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11170235.3A EP2535424B1 (en) 2011-06-16 2011-06-16 SNPs associated with thromboemoblic disease
PCT/EP2012/061185 WO2012171949A2 (en) 2011-06-16 2012-06-13 Thromboembolic disease

Publications (1)

Publication Number Publication Date
MX360663B true MX360663B (es) 2018-11-13

Family

ID=46320920

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2013014622A MX349347B (es) 2011-06-16 2012-06-13 Enfermedad tromboembolica.
MX2017009492A MX360663B (es) 2011-06-16 2012-06-13 Enfermedad tromboembolica.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2013014622A MX349347B (es) 2011-06-16 2012-06-13 Enfermedad tromboembolica.

Country Status (16)

Country Link
US (2) US9518297B2 (es)
EP (3) EP2535424B1 (es)
AR (1) AR086734A1 (es)
AU (1) AU2012269112B2 (es)
BR (1) BR112013032352A2 (es)
CA (1) CA2839368C (es)
CL (1) CL2013003605A1 (es)
DK (2) DK2535424T3 (es)
DO (1) DOP2013000296A (es)
ES (2) ES2547075T3 (es)
MX (2) MX349347B (es)
NO (1) NO2721172T3 (es)
PE (1) PE20141069A1 (es)
PT (2) PT2535424E (es)
RU (1) RU2606758C2 (es)
WO (1) WO2012171949A2 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10557170B2 (en) 2011-06-16 2020-02-11 Gendiag.Exe, S.L. Thromboembolic disease markers
EP2535424B1 (en) 2011-06-16 2015-08-05 Gendiag.exe, S.L. SNPs associated with thromboemoblic disease
JP2016522679A (ja) 2013-04-04 2016-08-04 プレジデント アンド フェローズ オブ ハーバード カレッジ ＣＲＩＳＰＲ／Ｃａｓ系を用いたゲノム編集の治療的使用
AU2016243583B2 (en) 2015-03-27 2022-03-10 President And Fellows Of Harvard College Modified T cells and methods of making and using the same
WO2017097854A1 (en) * 2015-12-08 2017-06-15 Umc Utrecht Holding B.V. Extracellular vesicle markers for stable angina and unstable angina
EP3551762B1 (en) * 2016-12-09 2022-01-26 Gene Gender S.R.L. Method and kit for predicting the risk of deep vein thrombosis and pulmonary embolism
US11377692B2 (en) 2016-12-09 2022-07-05 Gene Gender S.R.L. Method for predicting the risk of deep vein thrombosis and pulmonary embolism associated with hormonal preparations and hormone levels
WO2018195129A1 (en) 2017-04-17 2018-10-25 University Of Maryland, College Park Embryonic cell cultures and methods of using the same
WO2018215590A1 (en) * 2017-05-24 2018-11-29 Gendiag.Exe, S.L. Cancer-associated venous thromboembolic events
EP3749783A1 (en) * 2018-02-09 2020-12-16 Genincode UK, Ltd. Prediction of pregnancy loss
CN108642163B (zh) * 2018-05-16 2021-10-22 江苏中济万泰生物医药有限公司 一种人类红细胞abo血型基因分型引物组及应用
RU2710213C1 (ru) * 2018-12-17 2019-12-25 Федеральное государственное бюджетное научное учреждение "Томский национальный исследовательский медицинский центр Российской академии наук" (Томский НИМЦ) Способ определения вероятности церебральной и нецеребральной тромбоэмболии артерий большого круга кровообращения
EA038901B1 (ru) * 2019-09-27 2021-11-03 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр гематологии" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ гематологии" Минздрава России) Способ прогнозирования тромбоэмболических осложнений у женщин при носительстве мутаций гена протромбина [f2(20210)ga]
RU2722986C1 (ru) * 2019-12-24 2020-06-05 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр терапии и профилактической медицины" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ ТПМ" Минздрава России) Способ прогнозирования дополнительного риска тромбоэмболических осложнений у пациентов старческого возраста с фибрилляцией предсердий
CN114410766A (zh) * 2021-11-24 2022-04-29 广州知力医学诊断技术有限公司 一种血栓与出凝血性疾病检测panel及其应用
EP4194568A1 (en) * 2021-12-10 2023-06-14 Genincode Uk Limited Covid-19-associated venous thromboembolism
CN114214402B (zh) * 2021-12-29 2024-02-09 江苏意诺飞生物科技有限公司 血液高凝或静脉血栓风险基因多态性检测引物组、试剂盒及检测方法和应用
CN114937473B (zh) * 2022-07-20 2022-11-18 中日友好医院(中日友好临床医学研究所) 基于多基因突变的vte风险评估模型、构建方法及应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1975A (en) 1841-02-12 Manner of constructing corn-shellers
US4883750A (en) 1984-12-13 1989-11-28 Applied Biosystems, Inc. Detection of specific sequences in nucleic acids
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
AU690644B2 (en) 1994-02-14 1998-04-30 Rijksuniversiteit Leiden A method for screening for the presence of a genetic defect associated with thrombosis and/or poor anticoagulant response to activated protein C
US6159693A (en) 1998-03-13 2000-12-12 Promega Corporation Nucleic acid detection
DE60121342T2 (de) * 2000-08-11 2007-06-28 Idaho Technology, Inc., Salt Lake City Einfach markierte oligonukleotidsonden
US20030092019A1 (en) * 2001-01-09 2003-05-15 Millennium Pharmaceuticals, Inc. Methods and compositions for diagnosing and treating neuropsychiatric disorders such as schizophrenia
DE10237073A1 (de) * 2002-08-09 2004-02-19 Ogham Gmbh Methode zur Bestimmung eines erblichen Thromboserisikos mit DNA-arrays
US20050026168A1 (en) * 2002-12-13 2005-02-03 Genesis Group Inc. Method for the detection of risk factors associated with myocardial infarction
FR2852317B1 (fr) * 2003-03-13 2006-08-04 Biopuces a sondes et leurs methodes d'utilisation
JP5235274B2 (ja) * 2003-10-15 2013-07-10 株式会社サインポスト 疾患危険度の判定方法及び判定装置
US7879543B2 (en) * 2003-11-17 2011-02-01 Luminex Molecular Diagnostics, Inc. Method of detecting mutations associated with thrombosis
CN1930306A (zh) * 2004-01-15 2007-03-14 美国政府健康及人类服务部 发展用于血栓形成倾向识别的方法(mert)
CA2594730A1 (en) * 2005-01-13 2006-07-20 Progenika Biopharma, S.A. Methods and products for in vitro genotyping
WO2008020090A1 (es) * 2006-08-18 2008-02-21 Laboratorios Indas, S.A. Método y kit para diagnosticar el riesgo de desarrollar una enfermedad trombótica venosa
EP2535424B1 (en) 2011-06-16 2015-08-05 Gendiag.exe, S.L. SNPs associated with thromboemoblic disease

Also Published As

Publication number Publication date
EP2535424B1 (en) 2015-08-05
NO2721172T3 (es) 2018-06-09
RU2606758C2 (ru) 2017-01-10
WO2012171949A3 (en) 2013-02-21
EP2721172A2 (en) 2014-04-23
DK2535424T3 (en) 2015-09-14
DOP2013000296A (es) 2014-03-31
CL2013003605A1 (es) 2014-08-08
WO2012171949A2 (en) 2012-12-20
US20160102355A1 (en) 2016-04-14
US10023914B2 (en) 2018-07-17
AU2012269112B2 (en) 2015-09-03
PT2535424E (pt) 2015-10-29
AU2012269112A1 (en) 2014-01-30
ES2547075T3 (es) 2015-10-01
BR112013032352A2 (pt) 2018-10-30
MX2013014622A (es) 2014-03-27
DK2721172T5 (en) 2018-02-26
CA2839368A1 (en) 2012-12-20
PT2721172T (pt) 2018-02-21
RU2014101169A (ru) 2015-07-27
ES2663943T3 (es) 2018-04-17
EP2721172B1 (en) 2018-01-10
EP2799556A2 (en) 2014-11-05
DK2721172T3 (en) 2018-02-19
CA2839368C (en) 2018-12-04
US9518297B2 (en) 2016-12-13
MX349347B (es) 2017-07-25
EP2799556A3 (en) 2015-04-08
US20140221230A1 (en) 2014-08-07
EP2535424A1 (en) 2012-12-19
AR086734A1 (es) 2014-01-22
PE20141069A1 (es) 2014-09-06

Similar Documents

Publication Publication Date Title
MX2013014622A (es) Enfermedad tromboembolica.
MX2011013243A (es) Marcadores de riesgo para enfermedad cardiovascular.
MX2013000917A (es) Metodos para detectar las enfermedades o condiciones usando celulas fagociticas.
IL230621A (en) Soybean event pdab9582.814.19.1 detection method
EA201590027A1 (ru) Способы детекции заболеваний или состояний
NZ606725A (en) Methods for predicting anti-cancer response
GB201200658D0 (en) Methods,compositions,and kits for determining the presence/absence of a variant nucleic acid sequence
GB2485635B (en) Method for determining the presence or absence of different aneuploidies in a sample
WO2013033609A3 (en) Methods and compositions for the treatment and diagnosis of cancer
HUE051620T2 (hu) Multispecifikus, mutáns ellenanyag-Fab-fragmentumok
MX341840B (es) Biomarcadores de microarn indicativos de la enfermedad de alzheimer.
EP2818108A4 (en) METHOD FOR DETERMINING GLUCOSE CONCENTRATION IN HUMAN BLOOD
EP2687612A4 (en) Steel pipe quenching method
ITRM20120383A1 (it) Metodo e kit per la rivelazione di anticorpi.
MX2014001463A (es) Enfermedad cardiovascular.
EP4462120A3 (en) Methods for predicting response to parp inhibitors
WO2014135469A3 (en) Methods for detecting inflammatory disorders
MX337203B (es) Novedosas moleculas inhbidoras de jnk.
MX358474B (es) Biomarcadores salivales específicos para detección de riesgo, diagnóstico temprano, pronóstico y vigilancia de las enfermedades de alzheimer y de parkinson.
WO2013106844A3 (en) Methods and compositions for the treatment and diaginosis of pancreatic cancer
IN2015KN00073A (es)
EP2865636A4 (en) METHOD FOR PRODUCING A METAL NANODRAW OR A METAL NANONET
WO2012112958A3 (en) High-throughput assays to probe leukemia within the stromal niche
MX2016002529A (es) Marcadores de riesgo para cardiovasculopatias en pacientes con nefropatia cronica.
WO2012167163A3 (en) Methods and compositions for detecting endometrial or ovarian cancer